Sandra A. Gardiner
CIK 1218574 · View on SEC EDGAR ↗
First SEC filing: Feb. 28, 2022 · Latest: Feb. 28, 2022
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 16, 2026 | ADGM | A | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 14, 2021 | PLSE | A | 25,961 | — | — | 51,922 Direct | +100.00% | Acquired | (price as of 2026-08-21) |
| March 22, 2021 | PLSE | A | 18,000 | — | — | 18,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 23, 2021 | PLSE | A | 8,750 | — | — | 8,750 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 9, 2020 | PLSE | A | 25,961 | — | — | 25,961 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 18, 2019 | PLSE | A | 103,842 | — | — | 103,842 Direct | — | Acquired | (price as of 2026-08-21) |
| Nov. 18, 2019 | PLSE | A | 103,842 | — | — | 103,842 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 16, 2026 | ADGM | Non-qualified stock option (right to buy) [F1] | Common Stock (30,000) | $0.71 | June 16, 2036 | 30,000 | Acquired |
| Dec. 14, 2021 | PLSE | Stock Option (right to buy) | Common Stock | $13.94 | Nov. 18, 2029 | 25,961 | Acquired |
| March 22, 2021 | PLSE | Stock Option (right to buy) | Common Stock (18,000) | $24.03 | March 22, 2031 | 18,000 | Acquired |
| Feb. 23, 2021 | PLSE | Stock Option (right to buy) | Common Stock (8,750) | $10.66 | May 18, 2030 | 8,750 | Acquired |
| Dec. 9, 2020 | PLSE | Stock Option (right to buy) | Common Stock (25,961) | $13.94 | Nov. 18, 2029 | 25,961 | Acquired |
| Nov. 18, 2019 | PLSE | Stock Option (right to buy) | Common Stock (103,842) | $13.94 | Nov. 18, 2029 | 103,842 | Acquired |
| Nov. 18, 2019 | PLSE | Stock Option (right to buy) | Common Stock (103,842) | $13.94 | Nov. 18, 2029 | 103,842 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $400,000 | $171,200 | — | $230,310 | — | — | $1,255 | $802,765 |
| 2019 | $50,000 | $40,000 | — | — | — | — | $257 | $2,097,566 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.